TEXAS INSTRUMENTS INC·4

Apr 27, 4:31 PM ET

Leonard Shanon J 4

4 · TEXAS INSTRUMENTS INC · Filed Apr 27, 2026

Research Summary

AI-generated summary of this filing

Updated

Texas Instruments Sr. VP Leonard Shanon Exercises Options, Sells 18,189

What Happened

  • Leonard Shanon, Senior Vice President at Texas Instruments (TXN), exercised option awards and sold the resulting 18,189 shares on April 24, 2026.
  • He exercised four option tranches (1,700; 3,423; 5,529; 7,537 shares) paying a total exercise cost of $2,877,483, and sold all 18,189 shares in the open market for total proceeds of $5,055,707 (weighted avg sale price $277.95). Net proceeds (proceeds minus exercise cost) ≈ $2,178,224.
  • The filing shows the options were converted (reported as disposals of the derivative at $0.00) and the underlying shares were sold the same day.

Key Details

  • Transaction date: 2026-04-24; Form 4 filed 2026-04-27 (timely).
  • Sale details: 18,189 shares sold at a weighted-average price of $277.95; reported sale prices ranged from $277.36 to $278.30 (footnote F1).
  • Exercises: four option exercises with exercise prices and amounts:
    • 1,700 shares @ $104.41 = $177,497
    • 3,423 shares @ $130.52 = $446,770
    • 5,529 shares @ $169.23 = $935,673
    • 7,537 shares @ $174.81 = $1,317,543
  • Aggregate: 18,189 shares acquired via exercise (total exercise cost $2,877,483) and immediately sold for $5,055,707.
  • Shares owned after transaction: not disclosed in the provided filing excerpt.
  • Notable footnotes:
    • F1: sale price range and weighted-average note; detailed breakdown available on request.
    • F2–F5: the option tranches became exercisable in four equal annual installments beginning in 2020, 2021, 2022 and 2023, respectively (indicating vested/long-standing grants).

Context

  • This pattern — exercising vested options and selling the resulting shares the same day — is commonly a cashless exercise/liquidity event (options converted to shares and sold immediately). The filing shows both the option conversion (derivative reported as disposed) and the open-market sale.
  • The transaction is factual disclosure of insider activity and does not, by itself, indicate the insider’s view on the company’s future prospects.

Insider Transaction Report

Form 4
Period: 2026-04-24
Leonard Shanon J
Sr. Vice President
Transactions
  • Exercise/Conversion

    Common Stock

    2026-04-24$104.41/sh+1,700$177,49733,675 total
  • Exercise/Conversion

    Common Stock

    2026-04-24$130.52/sh+3,423$446,77037,098 total
  • Exercise/Conversion

    Common Stock

    2026-04-24$169.23/sh+5,529$935,67342,627 total
  • Exercise/Conversion

    Common Stock

    2026-04-24$174.81/sh+7,537$1,317,54350,164 total
  • Sale

    Common Stock

    [F1]
    2026-04-24$277.95/sh18,189$5,055,70731,975 total
  • Exercise/Conversion

    NQ Stock Option (Right to Buy)

    [F2]
    2026-04-241,7000 total
    Exercise: $104.41Exp: 2029-01-25Common Stock (1,700 underlying)
  • Exercise/Conversion

    NQ Stock Option (Right to Buy)

    [F3]
    2026-04-243,4230 total
    Exercise: $130.52Exp: 2030-01-24Common Stock (3,423 underlying)
  • Exercise/Conversion

    NQ Stock Option (Right to Buy)

    [F4]
    2026-04-245,5290 total
    Exercise: $169.23Exp: 2031-01-28Common Stock (5,529 underlying)
  • Exercise/Conversion

    NQ Stock Option (Right to Buy)

    [F5]
    2026-04-247,5370 total
    Exercise: $174.81Exp: 2032-01-27Common Stock (7,537 underlying)
Footnotes (5)
  • [F1]The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $277.36 to $278.3. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
  • [F2]The option became exercisable in four equal annual installments beginning on January 25, 2020.
  • [F3]The option became exercisable in four equal annual installments beginning on January 24, 2021.
  • [F4]The option became exercisable in four equal annual installments beginning on January 28, 2022.
  • [F5]The option became exercisable in four equal annual installments beginning on January 27, 2023.
Signature
/s/ Shannon Thompson, Attorney in Fact|2026-04-27

Documents

1 file
  • 4
    wk-form4_1777321899.xmlPrimary

    FORM 4